Key Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$317 Hold
38
– – ﹤0.01% 1253
2026
Q2
$380 Hold
38
– – ﹤0.01% 1278
2026
Q1
$362 Buy
+38
New +$295 ﹤0.01% 1324

Other funds holding BCRX

Key Financial's BCRX Position: Q3 2026 in Review

Key Financial held its BioCryst Pharmaceuticals (BCRX) position steady in Q3 2026 at 38 shares worth $317. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Key Financial first reported a position in BCRX in Q1 2026 and has held it in 3 quarters since. The position peaked at $380 in Q2 2026. 241 funds tracked by Wall St. Rank hold BCRX as of Q3 2026.

  • Key Financial held 38 shares of BioCryst Pharmaceuticals worth $317 as of Q3 2026.
  • Key Financial left its BioCryst Pharmaceuticals share count unchanged in Q3 2026.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1253 holding.
  • Key Financial first reported a position in BioCryst Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Key Financial's BioCryst Pharmaceuticals position peaked at $380 in Q2 2026.
  • 241 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.